{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Photosensitive+Epilepsy", "query": { "condition": "Photosensitive Epilepsy" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Photosensitive+Epilepsy&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T10:08:09.561Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03686033", "title": "A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Photosensitive Epilepsy" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "E2082", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 8, "start_date": "2018-10-31", "completion_date": "2019-06-18", "has_results": true, "last_update_posted_date": "2020-09-28", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 5, "location_summary": "Little Rock, Arkansas • Boise, Idaho • Baltimore, Maryland + 2 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Boise", "state": "Idaho" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03686033" }, { "nct_id": "NCT01363154", "title": "Prevention of Photoparoxysmal Abnormalities by Mozart K448", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Photoparoxysmal Abnormalities", "Epilepsy", "Seizures" ], "interventions": [ { "name": "Mozart K448", "type": "OTHER" }, { "name": "Beethoven's Für Elise", "type": "OTHER" }, { "name": "No music exposure", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "5 Years to 17 Years" }, "enrollment_count": 10, "start_date": "2010-11", "completion_date": "2013-02", "has_results": false, "last_update_posted_date": "2013-06-04", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01363154" }, { "nct_id": "NCT00894010", "title": "Photosensitivity Proof of Concept Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Photosensitive Epilepsy" ], "interventions": [ { "name": "carbamazepine 400mg", "type": "DRUG" }, { "name": "levetiracetam 1000mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Epilepsy Study Consortium", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 6, "start_date": "2009-05", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2012-03-05", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 2, "location_summary": "Baltimore, Maryland • New York, New York", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00894010" }, { "nct_id": "NCT00609245", "title": "Effect of Valproic Acid Concentration on Photic Response", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Photosensitive Epilepsy" ], "interventions": [ { "name": "Valproic Acid", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "15 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2007-12", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2017-06-14", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 2, "location_summary": "Chesterfield, Missouri • Nashville, Tennessee", "locations": [ { "city": "Chesterfield", "state": "Missouri" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00609245" }, { "nct_id": "NCT03603639", "title": "A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Photosensitive Epilepsy" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "E2730", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 6, "start_date": "2018-07-27", "completion_date": "2019-02-14", "has_results": true, "last_update_posted_date": "2022-05-04", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 5, "location_summary": "Little Rock, Arkansas • Boise, Idaho • Baltimore, Maryland + 2 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Boise", "state": "Idaho" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03603639" }, { "nct_id": "NCT02564029", "title": "PF-06372865 in Subjects With Photosensitive Epilepsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Reflex Epilepsy, Photosensitive" ], "interventions": [ { "name": "PF-06372865", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Lorazepam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 7, "start_date": "2015-12-16", "completion_date": "2017-02-07", "has_results": true, "last_update_posted_date": "2018-03-14", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 16, "location_summary": "Boise, Idaho • Baltimore, Maryland • St Louis, Missouri + 3 more", "locations": [ { "city": "Boise", "state": "Idaho" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02564029" }, { "nct_id": "NCT00979004", "title": "A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "ICA-105665", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 13, "start_date": "2009-09", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2012-10-04", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 3, "location_summary": "Little Rock, Arkansas • Chesterfield, Missouri • Nashville, Tennessee", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Chesterfield", "state": "Missouri" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00979004" }, { "nct_id": "NCT03790137", "title": "Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Photosensitive Epilepsy" ], "interventions": [ { "name": "Fenfluramine Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Elizabeth Anne Thiele", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "4 Years to 25 Years" }, "enrollment_count": 20, "start_date": "2019-05-31", "completion_date": "2024-07-19", "has_results": true, "last_update_posted_date": "2024-11-06", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03790137" }, { "nct_id": "NCT06525649", "title": "A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Photosensitive Epilepsy", "Epilepsy" ], "interventions": [ { "name": "NPT 2042", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeuroPro Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 5, "start_date": "2024-08-21", "completion_date": "2025-06-26", "has_results": false, "last_update_posted_date": "2025-07-16", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 2, "location_summary": "Little Rock, Arkansas • Boise, Idaho", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Boise", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT06525649" }, { "nct_id": "NCT03580707", "title": "Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Photosensitive Epilepsy" ], "interventions": [ { "name": "BRV vs LEV in randomized double blinded, crossover fashion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rosenfeld, William E., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 16, "start_date": "2018-06-01", "completion_date": "2018-12-31", "has_results": false, "last_update_posted_date": "2019-03-26", "last_synced_at": "2026-07-22T10:08:09.561Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03580707" } ] }